What comes next? Sequencing therapies in advanced UC
Raising the Bar in Bladder Cancer Care is a three-part podcast series featuring leading experts who discuss the evolving treatment landscape in bladder cancer. Through evidence-based discussions and practical insights, the series explores treatment sequencing in advanced urothelial carcinoma, new perioperative approaches in muscle-invasive bladder cancer, and the importance of multidisciplinary strategies to optimize patient care and adverse event management.
Join Enrique Grande and María T Bourlon as they discuss guideline-recommended treatment selection and sequencing in advanced urothelial carcinoma, before exploring the evolving role of biomarkers and how newer therapies are redefining treatment success.
Start this program
Enrique Grande
María Teresa Bourlon
- Select and sequence guideline-recommended treatment for advanced urothelial carcinoma based on patient factors, prior therapies and emerging evidence on optimal sequencing of treatments
In addition to the expert faculty, Springer Healthcare IME planners and staff include Kamran Ahmad and Rebecca Cox. The planning committee have no financial relationships to disclose.
All relevant financial relationships of the faculty have been mitigated.
Urologists, oncologists, surgeons, oncology nurses, physician assistants, pathologists and pharmacists involved in the care of patients with advanced UC and MIBC, and all other healthcare professionals (HCPs) managing bladder cancer.
Other learning activities in this program
